Identification of polymorphisms in genes associated with drug resistance in Plasmodium falciparum isolates from school-age children in Kinshasa, Democratic Republic of Congo
- PMID: 35051550
- DOI: 10.1016/j.parint.2022.102541
Identification of polymorphisms in genes associated with drug resistance in Plasmodium falciparum isolates from school-age children in Kinshasa, Democratic Republic of Congo
Abstract
Background: The emergence and spread of Plasmodium falciparum parasites resistant to antimalarial drugs constitutes an obstacle to malaria control and elimination. This study aimed to identify the prevalence of polymorphisms in pfk13, pfmdr1, pfdhfr, pfdhps and pfcrt genes in isolates from asymptomatic and symptomatic school-age children in Kinshasa.
Methods: Nested-PCR followed by sequencing was performed for the detection of pfk13, pfmdr1, pfdhfr, pfdhps and pfcrt polymorphisms.
Results: Two mutations in pfk13, C532S and Q613E were identified in the Democratic Republic of Congo for the first time. The prevalence of the drug-resistance associated mutations pfcrt K76T, pfdhps K540E and pfmdr1 N86Y was low, being 27%, 20% and 9%, respectively.
Conclusion: We found a low prevalence of genetic markers associated with chloroquine and sulfadoxine-pyrimethamine resistance in Kinshasa. Furthermore, no mutations previously associated with resistance against artemisinin and its derivatives were observed in the pfK13 gene. These findings support the continued use of ACTs and IPTp-SP. Continuous molecular monitoring of antimalarial resistance markers is recommended.
Keywords: Democratic Republic of Congo; Drug resistance; Malaria; Plasmodium falciparum; School-age children.
Copyright © 2022. Published by Elsevier B.V.
Similar articles
-
The landscape of drug resistance in Plasmodium falciparum malaria in the Democratic Republic of Congo: a mapping systematic review.Trop Med Health. 2023 Nov 15;51(1):64. doi: 10.1186/s41182-023-00551-7. Trop Med Health. 2023. PMID: 37968745 Free PMC article. Review.
-
Molecular surveillance of anti-malarial drug resistance genes in Plasmodium falciparum isolates in Odisha, India.Malar J. 2022 Dec 24;21(1):394. doi: 10.1186/s12936-022-04403-3. Malar J. 2022. PMID: 36566182 Free PMC article.
-
Assessment of Plasmodium falciparum anti-malarial drug resistance markers in pfk13-propeller, pfcrt and pfmdr1 genes in isolates from treatment failure patients in Democratic Republic of Congo, 2018-2019.Malar J. 2021 Mar 11;20(1):144. doi: 10.1186/s12936-021-03636-y. Malar J. 2021. PMID: 33706773 Free PMC article.
-
Assessment of Plasmodium falciparum drug resistance associated molecular markers in Mandla, Madhya Pradesh, India.Malar J. 2023 Dec 11;22(1):375. doi: 10.1186/s12936-023-04817-7. Malar J. 2023. PMID: 38072967 Free PMC article.
-
Insight into molecular diagnosis for antimalarial drug resistance of Plasmodium falciparum parasites: A review.Acta Trop. 2023 May;241:106870. doi: 10.1016/j.actatropica.2023.106870. Epub 2023 Feb 26. Acta Trop. 2023. PMID: 36849091 Review.
Cited by
-
An overview of artemisinin-resistant malaria and associated Pfk13 gene mutations in Central Africa.Parasitol Res. 2024 Jul 18;123(7):277. doi: 10.1007/s00436-024-08301-2. Parasitol Res. 2024. PMID: 39023630 Review.
-
The landscape of drug resistance in Plasmodium falciparum malaria in the Democratic Republic of Congo: a mapping systematic review.Trop Med Health. 2023 Nov 15;51(1):64. doi: 10.1186/s41182-023-00551-7. Trop Med Health. 2023. PMID: 37968745 Free PMC article. Review.
-
Self-medication and Anti-malarial Drug Resistance in the Democratic Republic of the Congo (DRC): A silent threat.Trop Med Health. 2022 Oct 4;50(1):73. doi: 10.1186/s41182-022-00466-9. Trop Med Health. 2022. PMID: 36195896 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources